Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Cara A. Rosenbaum"'
Autor:
Robert J. Kimmerling, Mark M. Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C. Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S. Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A. Criscitiello, Ruben Niesvizky, Marlise R. Luskin, Samir Parekh, Cara A. Rosenbaum, Anobel Tamrazi, Clifford A. Reid
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-14 (2022)
A pipeline for drug sensitivity testing using cell mass from sample collection to data analysis is presented.
Externí odkaz:
https://doaj.org/article/4fdd94008c854d24ab6da10668f5587e
Autor:
Robert J. Kimmerling, Mark M. Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C. Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S. Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A. Criscitiello, Ruben Niesvizky, Marlise R. Luskin, Samir Parekh, Cara A. Rosenbaum, Anobel Tamrazi, Clifford A. Reid
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/8f694796722146e58147a51a6af93ce3
Autor:
Cara A. Rosenbaum, Umut Özbek, Larysa Sanchez, Jonathan Lagdameo, Alex Abrahams, Hani Hassoun, Oscar Lahoud, Ruben Niesvizky, Heather J. Landau, Keren Osman
Publikováno v:
Blood Advances. 6:5436-5439
Autor:
Shaji K Kumar, Melissa Alsina, Betsy Laplant, Ashraf Z. Badros, Al-Ola Abdallah, Rafat Abonour, Erik J Asmus, Binod Dhakal, Cara A. Rosenbaum, Daniel Egan, Manisha Bhutani, Andrzej Jakubowiak, Brian G.M. Durie
Publikováno v:
Blood. 140:1830-1832
Autor:
Morie A. Gertz, Rafat Abonour, Sarah N. Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany P. Quock, Cara A. Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A. Tuchman, Ronald Witteles, Irina Yermilov, Michael S. Broder
Publikováno v:
Blood. 140:13129-13131
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53454f0abd907aba2e1ad9eb141d8e39
https://doi.org/10.1158/2643-3230.22542939
https://doi.org/10.1158/2643-3230.22542939
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Patients with multiple myeloma have a compromised immune system, due to both the disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID-19. Here, we report outcomes and risk factors for serious disease in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc094855f250432258fa025fb0580e50
https://doi.org/10.1158/2643-3230.c.6550092
https://doi.org/10.1158/2643-3230.c.6550092
Autor:
Lisette Stork-Sloots, David S. Siegel, Martin H. van Vliet, David H. Vesole, Cara A. Rosenbaum, Femke A. de Snoo, Ajay K. Nooka, Durga Prasad Dash, Adriana C Rossi, Ruben Niesvizky, Parameswaran Hari, Cesar Rodriguez, Sena Zümrütçü, Frits van Rhee, Suzanne Lentzsch, Pritish K. Bhattacharyya, Binod Dhakal, Saad Z. Usmani, Divaya Bhutani, Noa Biran
Publikováno v:
eJHaem. 2:375-384
Multiple myeloma (MM) is a heterogeneous hematologic malignancy associated with several risk factors including genetic aberrations which impact disease response and survival. Thorough risk classification is essential to select the best clinical strat
Autor:
Mateo Mejia Saldarriaga, Aubrie Sowa, David S Jayabalan, Cara A. Rosenbaum, Roger Pearse, Jorge Monge, Ruben Niesvizky, Mark Bustoros
Publikováno v:
Blood. 140:9951-9952
Autor:
Mateo Mejia Saldarriaga, David S Jayabalan, Aubrie Sowa, Jorge Monge, Cara A. Rosenbaum, Roger Pearse, Ruben Niesvizky, Sanjay Patel, Mark Bustoros
Publikováno v:
Blood. 140:4238-4239